Ascletis Pharma Inc
Ascletis Pharma's GHG Emissions Data Preview
In 2023, Ascletis Pharma completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Ascletis Pharma has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Ascletis Pharma's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Ascletis Pharma amounted to 3,221.47 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Ascletis Pharma increased by 42.95%, suggesting that the company faced challenges in reducing its emissions from its core operations.
Ascletis Pharma's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Ascletis Pharma's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Ascletis Pharma were 421.6 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Compared to the previous year (2022), Ascletis Pharma's Scope 1 emissions increased by 1,792.28%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
What are Ascletis Pharma's Scope 2 emissions?
In 2023, Ascletis Pharma reported Scope 2 greenhouse gas (GHG) emissions of 2,799.87 tCOâ‚‚e without specifying the calculation method.
Has Ascletis Pharma reduced its Scope 2 emissions over time?
Compared to the previous year (2022), Ascletis Pharma's Scope 2 emissions (Unspecified Calculation Method) rose by 25.48% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy
What methodology does Ascletis Pharma use for Scope 2 reporting?
In 2023, Ascletis Pharma reported its Scope 2 emissions using an unspecified methodology.
Ascletis Pharma's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)